Roswell Park dermatology expert Oscar Colegio dies at 47

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Oscar Colegio, the Lawrence P. & Joan Castellani Family Endowed Chair in Dermatology at Roswell Park Comprehensive Cancer Center, died unexpectedly last weekend at a family residence in Connecticut. He was 47.

Colegio relocated to Buffalo when he was recruited to head Roswell Park’s dermatology program in 2018. He had previously served as associate professor of dermatology, pathology and surgery at Yale University.

“Our hearts are with Dr. Colegio’s family,” Roswell Park President and CEO Candace S. Johnson, said in a statement. “In only two years’ time, he became a dear friend, trusted physician and valued colleague to so many. He embraced his adoptive home of Buffalo and the Elmwood Village with warmth and friendship. Given who Oscar was personally and professionally, all that he accomplished and the passion with which he pursued his work, this loss leaves an enormous hole.”

A clinician and scientist with more than 20 years of experience, Colegio was president of the International Immunosuppression and Transplant Skin Cancer Collaborative, a professional society dedicated to understanding skin cancer in organ transplant recipients.

He specialized in cutaneous squamous cell carcinoma, basal cell carcinoma, melanoma, immunology, immunodeficiency-associated skin cancers and solid organ transplantation. Consistently named to the national Top Doctors list, he earned doctoral and medical degrees from Yale University in New Haven, Connecticut.

Colegio is survived by his wife, Brenda, and two sons, Otto and Austin. A fund will be established in his name to support research on cancers of the skin. A gift in his memory may be designated to the fund here.

Table of Contents

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login